442 related articles for article (PubMed ID: 33385130)
21. Conversion of hepatitis B virus relaxed circular to covalently closed circular DNA is supported in murine cells.
Wei L; Cafiero TR; Tseng A; Gertje HP; Berneshawi A; Crossland NA; Ploss A
JHEP Rep; 2022 Sep; 4(9):100534. PubMed ID: 36035363
[TBL] [Abstract][Full Text] [Related]
22. Dual role of neddylation in transcription of hepatitis B virus RNAs from cccDNA and production of viral surface antigen.
Qu B; Nebioglu F; Leuthold MM; Ni Y; Mutz P; Beneke J; Erfle H; Vondran FWR; Bartenschlager R; Urban S
JHEP Rep; 2022 Oct; 4(10):100551. PubMed ID: 36124123
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis B virus nucleocapsid uncoating: biological consequences and regulation by cellular nucleases.
Hu J; Tang L; Cheng J; Zhou T; Li Y; Chang J; Zhao Q; Guo JT
Emerg Microbes Infect; 2021 Dec; 10(1):852-864. PubMed ID: 33870849
[TBL] [Abstract][Full Text] [Related]
24. Heat Shock Protein Family A Member 1 Promotes Intracellular Amplification of Hepatitis B Virus Covalently Closed Circular DNA.
Tang L; An P; Zhao Q; Winkler CA; Chang J; Guo JT
J Virol; 2023 Jan; 97(1):e0126122. PubMed ID: 36519896
[TBL] [Abstract][Full Text] [Related]
25. [Novel vector preS1-tp fusion protein effectively inhibits hepatitis B virus replication and cccDNA synthesis by mediating hepatitis B virus targeting sequence small interfering RNA].
Zeng YL; Gao F; Zhang C; Wei JF; Ma L; Ding GG; Li W; Shang J; Kang Y
Zhonghua Gan Zang Bing Za Zhi; 2021 Feb; 29(2):126-132. PubMed ID: 33685080
[No Abstract] [Full Text] [Related]
26. Reduction of hepatitis B surface antigen and covalently closed circular DNA by nucleos(t)ide analogues of different potency.
Wong DK; Seto WK; Fung J; Ip P; Huang FY; Lai CL; Yuen MF
Clin Gastroenterol Hepatol; 2013 Aug; 11(8):1004-10.e1. PubMed ID: 23376799
[TBL] [Abstract][Full Text] [Related]
27. HepG2-NTCP Subclones Exhibiting High Susceptibility to Hepatitis B Virus Infection.
Zahoor MA; Kuipery A; Mosa AI; Gehring AJ; Feld JJ
Viruses; 2022 Aug; 14(8):. PubMed ID: 36016422
[TBL] [Abstract][Full Text] [Related]
28. HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B.
Nassal M
Gut; 2015 Dec; 64(12):1972-84. PubMed ID: 26048673
[TBL] [Abstract][Full Text] [Related]
29. SUMO Modification of Hepatitis B Virus Core Mediates Nuclear Entry, Promyelocytic Leukemia Nuclear Body Association, and Efficient Formation of Covalently Closed Circular DNA.
Hofmann S; Plank V; Groitl P; Skvorc N; Hofmann K; Luther J; Ko C; Zimmerman P; Bruss V; Stadler D; Carpentier A; Rezk S; Nassal M; Protzer U; Schreiner S
Microbiol Spectr; 2023 Jun; 11(3):e0044623. PubMed ID: 37199632
[TBL] [Abstract][Full Text] [Related]
30. Ergosterol peroxide inhibits HBV infection by inhibiting the binding of the pre-S1 domain of LHBsAg to NTCP.
Huang H; Huang HC; Chiou WC; Lin LC; Chen JC; Liu HK; Lai YH; Huang C
Antiviral Res; 2021 Nov; 195():105184. PubMed ID: 34627935
[TBL] [Abstract][Full Text] [Related]
31. HIRA Supports Hepatitis B Virus Minichromosome Establishment and Transcriptional Activity in Infected Hepatocytes.
Locatelli M; Quivy JP; Chapus F; Michelet M; Fresquet J; Maadadi S; Aberkane AN; Diederichs A; Lucifora J; Rivoire M; Almouzni G; Testoni B; Zoulim F
Cell Mol Gastroenterol Hepatol; 2022; 14(3):527-551. PubMed ID: 35643233
[TBL] [Abstract][Full Text] [Related]
32. Molecular clones of genetically distinct hepatitis B virus genotypes reveal distinct host and drug treatment responses.
Liu Y; Park D; Cafiero TR; Bram Y; Chandar V; Tseng A; Gertje HP; Crossland NA; Su L; Schwartz RE; Ploss A
JHEP Rep; 2022 Sep; 4(9):100535. PubMed ID: 36035359
[TBL] [Abstract][Full Text] [Related]
33. Conserved Lysine Residues of Hepatitis B Virus Core Protein Are Not Required for Covalently Closed Circular DNA Formation.
Hong X; Hu J
J Virol; 2022 Aug; 96(15):e0071822. PubMed ID: 35867543
[TBL] [Abstract][Full Text] [Related]
34. Novel Potent Capsid Assembly Modulators Regulate Multiple Steps of the Hepatitis B Virus Life Cycle.
Lahlali T; Berke JM; Vergauwen K; Foca A; Vandyck K; Pauwels F; Zoulim F; Durantel D
Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30012770
[TBL] [Abstract][Full Text] [Related]
35. Identification of disubstituted sulfonamide compounds as specific inhibitors of hepatitis B virus covalently closed circular DNA formation.
Cai D; Mills C; Yu W; Yan R; Aldrich CE; Saputelli JR; Mason WS; Xu X; Guo JT; Block TM; Cuconati A; Guo H
Antimicrob Agents Chemother; 2012 Aug; 56(8):4277-88. PubMed ID: 22644022
[TBL] [Abstract][Full Text] [Related]
36. Region-Specific Hepatitis B Virus Genome Exposure from Nucleocapsid Modulated by Capsid Linker Sequence and Inhibitor: Implications for Uncoating.
Xi J; Cui X; Liu K; Liu H; Wang J; Hu J
J Virol; 2022 Apr; 96(8):e0039922. PubMed ID: 35389266
[TBL] [Abstract][Full Text] [Related]
37. Efficient long-term amplification of hepatitis B virus isolates after infection of slow proliferating HepG2-NTCP cells.
König A; Yang J; Jo E; Park KHP; Kim H; Than TT; Song X; Qi X; Dai X; Park S; Shum D; Ryu WS; Kim JH; Yoon SK; Park JY; Ahn SH; Han KH; Gerlich WH; Windisch MP
J Hepatol; 2019 Aug; 71(2):289-300. PubMed ID: 31077792
[TBL] [Abstract][Full Text] [Related]
38. EGF receptor inhibitors comprehensively suppress hepatitis B virus by downregulation of STAT3 phosphorylation.
Gan CJ; Li WF; Li CN; Li LL; Zhou WY; Peng XM
Biochem Biophys Rep; 2020 Jul; 22():100763. PubMed ID: 32322693
[TBL] [Abstract][Full Text] [Related]
39. [The potential use of serum HBV RNA to guide the functional cure of chronic hepatitis B].
Lu FM; Wang J; Chen XM; Jiang JN; Zhang WH; Zhao JM; Ren H; Hou JL; Xia NS
Zhonghua Gan Zang Bing Za Zhi; 2017 Feb; 25(2):105-110. PubMed ID: 28297795
[TBL] [Abstract][Full Text] [Related]
40. N-Linked Glycosylation Is Not Essential for Sodium Taurocholate Cotransporting Polypeptide To Mediate Hepatitis B Virus Infection
Lee J; Zong L; Krotow A; Qin Y; Jia L; Zhang J; Tong S; Li J
J Virol; 2018 Aug; 92(15):. PubMed ID: 29793953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
